Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Dale W Usner"'
Autor:
Jason Bacharach, Long V. Doan, Kerry G. Stephens, Dale W. Usner, Angela C. Kothe, L. Jay Katz, Tomas Navratil
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 9, Pp 2357-2367 (2024)
Abstract Introduction This study was conducted to analyze and compare the intraocular pressure (IOP) treatment effect of the slow-eluting (SE) travoprost intracameral implant to the IOP treatment effect of topical prostaglandin analog (PGA) monothera
Externí odkaz:
https://doaj.org/article/c49e87653c9144ec87f3d9d99da00a54
Autor:
Steven R. Sarkisian, Robert E. Ang, Andy M. Lee, John P. Berdahl, Sebastian B. Heersink, James H. Burden, Long V. Doan, Kerry G. Stephens, David Applegate, Angela C. Kothe, Dale W. Usner, L. Jay Katz, Tomas Navratil
Publikováno v:
Ophthalmology and Therapy, Vol 13, Iss 4, Pp 995-1014 (2024)
Abstract Introduction This prospective, multicenter, randomized, double-masked pivotal phase 3 trial evaluated the efficacy and safety of the travoprost intracameral SE-implant (slow-eluting implant, the intended commercial product) and FE-implant (f
Externí odkaz:
https://doaj.org/article/052e71c316ce4ce284958e91b53816ab
Autor:
Casey Kopczynski, Nancy Ramirez, Savak Teymoorian, Richard A Lewis, Dale W. Usner, Hayley McKee, Theresa Heah, Jacob W. Brubaker
Publikováno v:
Ophthalmology Glaucoma. 3:327-338
Purpose A phase 3 trial (MERCURY-1) investigated efficacy and safety of a once-daily, fixed-dose combination (FDC) of netarsudil and latanoprost, compared with each active component, in reducing elevated intraocular pressure (IOP) in patients with op
Autor:
Thomas R. Walters, Angela C. Kothe, José L. Boyer, Dale W. Usner, Krisol Lopez, Brigitte Duquesroix, Robert D. Fechtner, Tomas Navratil
Publikováno v:
Journal of glaucoma. 31(6)
NCX 470 0.042% and 0.065% were statistically superior in intraocular pressure (IOP) lowering to latanoprost 0.005%, and NCX 470 0.021% was noninferior. All NCX 470 concentrations were safe and well tolerated.The purpose of this study was to compare v
Autor:
Albert S. Khouri, Janet B. Serle, Jason Bacharach, Dale W. Usner, Richard A. Lewis, Puiwah Braswell, Casey C. Kopczynski, Theresa Heah, Robert Benza, John W. Boyle, Michelle Butler, Leonard Robert Cacioppo, Jose F. Cardona, Valerie A. Colborn, Douglas G. Day, David T. Douglass, Sherif M. El-Harazi, Deepta Ghate, Carl Hartman, Robert F. Haverly, Barry Katzman, Max Kim, Edward Y. Koo, Michael S. Korenfeld, Bradley Kwapiszeski, Lydia Lane, Christopher Lin, Andrew Gardner Logan, Jeffrey Raymond Lozier, Henry McQuirter, Thomas K. Mundorf, Kenneth Olander, Richard J. Ou, Gregory J. Panzo, James H. Peace, Eugene E. Protzko, Robert Ritch, Kenneth Sall, Barry A. Schechter, Samuel Eric Seltzer, Pankajkumar G. Shah, Elizabeth Sharpe, Philip Lee Shettle, David G. Shulman, Inder Paul Singh, Stacy R. Smith, Stephen E. Smith, Robert John Smyth-Medina, Robert C. Sorenson, Richard Sturm, Gregory M. Sulkowski, James D. Sutton, Michael Tepedino, Julie Tsai, Carl B. Tubbs, David B. Tukel, Thomas Richard Walters, David L. Wirta
Publikováno v:
American Journal of Ophthalmology. 204:97-104
To compare the intraocular pressure (IOP)-lowering efficacy and safety of netarsudil once daily (QD) and timolol twice daily (BID).Double-masked, randomized, phase 3, noninferiority study.Patients with open-angle glaucoma or ocular hypertension (unme
Autor:
Francis S. Mah, Nancy Ramirez-Davis, Theresa Heah, Janet B. Serle, Michael B. Raizman, Terry Kim, Dale W Usner, Malik Y. Kahook, Gary D. Novack, Casey Kopczynski
Publikováno v:
American Journal of Ophthalmology. 200:130-137
Purpose To evaluate netarsudil 0.02% ophthalmic solution in patients with open-angle glaucoma (OAG) and ocular hypertension (OHT). Design Double-masked, randomized, multicenter, parallel-group, noninferiority clinical study. Methods After a washout o
Autor:
Dale W. Usner, Thomas Schlüter, George W Ousler, Joseph B. Ciolino, Blair E. Boehmer, Eugene B McLaurin, David Wirta, John D. Sheppard, Sonja Krösser, Meides Alice
Publikováno v:
Cornea
Dry eye disease (DED) is defined by the International Dry Eye Workshop (TFOS DEWS II) as a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, and accompanied by ocular symptoms, in which tear film in
Autor:
Rocket Study Groups, Nancy Ramirez-Davis, Dale W. Usner, Eugene B McLaurin, Casey Kopczynski, Gary D. Novack, Janet B. Serle, Theresa Heah, L. Jay Katz
Publikováno v:
American Journal of Ophthalmology. 186:116-127
To evaluate the efficacy and ocular and systemic safety of netarsudil 0.02% ophthalmic solution, a rho-kinase inhibitor and norepinephrine transporter inhibitor, in patients with open-angle glaucoma and ocular hypertension.Double-masked, randomized n
Autor:
Yao Liu, Brennan Greene, Jacob W. Brubaker, Kevin Y. Jong, Scott Corin, Justus W. Thomas, Vickas Khemsara, Ehsan Sadri, Thomas D. LoBue, William J. Flynn, Navin H Tekwani, William C. Christie, Farrell C. Tyson, Matthew J. Swanic, Damien F. Goldberg, Sanjay Asrani, Ranjan P. Malhotra, Matthew G. McMenemy, Karen L. Klugo, Lawrence B. Katzen, John F. Kozlovsky, Bernard R. Perez, Alan L. Robin, Stephen Vold, John Nicolau, Mihir Parikh, Dale W Usner, Ettaleah C. Bluestein, John S. Cohen, Stacey L. Ackerman, Thomas T. Henderson, Kundandeep Nagi, Nicole M. Collins, Jodi Ian Luchs, Robert M. Saltzmann, Andrew Mays, Jay Mulaney, Jody R. Piltz-Seymour, Sayoko E. Moroi, Fiaz Zaman, Savak Teymoorian, Eran Duzman, Howard I. Schenker, Casey Kopczynski, Gary Jerkins, Eugene B. McLaurin, Mark J. Weiss, Kent Bashford, Todd Daynes, Joseph P. Gira, Brian E. Flowers, Theresa Heah, Scott B. Han, Donna Leonardo, Michael Depenbusch, Janet B. Serle, Raymond Fong, James D. Boyce, James D. Branch, Louis M. Alpern, Lee S. Peplinski, Jay R. Patel, El-Roy Dixon, Richard A Lewis, Satish Modi
Publikováno v:
American journal of ophthalmology. 207
To compare the ocular hypotensive efficacy and safety of a fixed-dose combination (FDC) of the Rho kinase inhibitor netarsudil and latanoprost vs monotherapy with netarsudil or latanoprost.Three-month primary endpoint analysis of a randomized, double
Autor:
Casey Kopczynski, Thomas R Walters, Dale W. Usner, Iqbal Ike K. Ahmed, Jae Lopez, Theresa Heah, Richard A Lewis
Publikováno v:
Ophthalmology. Glaucoma. 2(5)
To compare the ocular hypotensive efficacy and safety of a once-daily (pm) fixed-dose combination (FDC) product containing netarsudil 0.02% and latanoprost 0.005% with monotherapy with netarsudil or latanoprost. Netarsudil is a Rho kinase inhibitor t